These findings reinforce the concept that inflammation, as indexed by CRP, may serve as a biological bridge linking depression and cardiometabolic risk, with implications for integrated treatment strategies targeting both psychological and metabolic health [75]. This evidence concerns the gene CRP and depressive symptom measurement.